DOXIMITY INC-CLASS A
DOCSNYSETrading Snapshot
- Day Range
- $25.99 – $26.43
- 52-Week Range
- $17.15 – $76.51
- Volume
- $6.92B
- Avg Volume
- $8.07B
- Shares Outstanding
- 179.8M
- Next Earnings
- Oct 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $645M
- Last Q Revenue
- $157M
- P/E Ratio
- 27.6
- P/S Ratio
- 7.0x
- EPS (TTM)
- $0.84
- Dividend Yield
- —
Why Investors Own DOCS
- ✓High-growth profile — revenue up -8.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 35% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About DOXIMITY INC-CLASS A
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Wells Fargo Downgrades Doximity (DOCS)
DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures
Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 7.3% year on year to $156.6 million. The company expects next quarter’s revenue to be around $170.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.29 per share was 4.2% below analysts’ consensus estimates.
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
Doximity Draws Its First Downgrade Days After Its Pop
Wells Fargo cut the stock to Underweight with an $18 target
Wells Fargo Downgrades Doximity to Underweight, Maintains Price Target to $18
Wells Fargo analyst Stan Berenshteyn downgrades Doximity (NYSE:DOCS) from Equal-Weight to Underweight and maintains the price target from $18 to $18.
Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth
Doximity’s updated fair value estimate has moved from US$24.37 to US$28.00, which represents roughly a 15% uplift in the latest model. This shift lines up with the split analyst narrative, where some firms point to improving execution and AI traction, while others focus on execution risk, competition in healthcare AI, and the path for longer term growth. As you read on, you will see how to track these changing views and what to watch as the story around Doximity continues to evolve. Stay...